Willow vs HumeCare+ — structured support or bundled protocol
Quick verdict: Willow focuses on an oral GLP-1 program framed as a structured weight management journey with progress tracking and follow-up support, while HumeCare+ sells a bundled GLP-1 protocol that adds glycine, B vitamins, body-composition scans, and a 10%-or-money-back promise over six months.
Explore Willow’s tracked oral GLP-1 program
Willow vs HumeCare+: what differs most
This comparison centers on the three most distinctive differences supported by the sources: care model and follow-up, medication protocol and added ingredients, and measurement and guarantees. Both require a licensed clinician to determine medical appropriateness. Below we compare those areas directly.
Care model and follow-up
Willow positions itself as a telehealth-first weight management program emphasizing progress tracking tools and follow-up consultations. Its messaging frames treatment as a structured journey rather than a stand-alone medication subscription. HumeCare+ also bundles clinician access and an app, but emphasizes continuous physician optimization and 24/7 clinician access plus an app for medication tracking and food logging.
See Willow’s digital follow-up features
Medication protocol and supportive ingredients
Willow advertises oral GLP-1 without specifying bundled supportive ingredients in the captured evidence. HumeCare+ explicitly pairs physician-prescribed compounded semaglutide or tirzepatide with glycine and vitamins B6 and B12, positioning those additions as muscle-preserving and side-effect mitigation measures. HumeCare+ lists semaglutide from $199/month and tirzepatide with B12 and glycine from $299/month. Willow’s starting price is documented as 299.
Review HumeCare+ compounded GLP-1 protocols
Measurement, tracking, and guarantees
Willow emphasizes progress tracking as part of its behavioral support but the captured page did not include a money-back guarantee or body-composition scans. HumeCare+ includes monthly body-composition scans to track fat versus lean mass and advertises a 10%-or-money-back promise over six months, with terms to verify directly. HumeCare+ also reports internal headline outcomes and notes that individual results may vary.
Comparison table: Willow vs HumeCare+
| Criteria | Willow | HumeCare+ |
|---|---|---|
| Care model | Telehealth-first with licensed telehealth team and follow-up consultations | Physician-prescribed protocol with continuous physician optimization and 24/7 clinician access |
| Medication type | Oral GLP-1 program (details in captured evidence limited) | Compounded semaglutide or tirzepatide dispensed from U.S. pharmacies |
| Supportive ingredients | No bundled supportive ingredients captured | Glycine plus vitamins B6 and B12 built into the formulation |
| Tracking and measurement | Progress tracking tools and follow-up support | Monthly body-composition scans tracking lean mass and an app for tracking |
| Pricing (starting) | Starting price documented as 299 | Semaglutide from $199/mo; tirzepatide protocol from $299/mo |
| Guarantee | No money-back promise captured | 10%-or-money-back promise over six months, terms apply |
| Regulatory note | Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-evaluated for safety, quality, or efficacy |
Other factors from the sources
Willow markets a simple digital workflow and positions behavioral scaffolding as central to turning medication effect into sustainable outcomes. HumeCare+ highlights free next-day delivery, cancel anytime policies, and promotional pricing reflected on its landing pages. HumeCare+ also documents that its claims are based on an internal analysis of 6,846 members and that headline results are company-reported; it cautions that individual results may vary.
How safety and regulatory points compare
Both sources note that treatment is available only when a licensed clinician determines it is medically appropriate. Both include regulatory reminders about compounded medications: Willow notes compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. HumeCare+ states compounded medications are not evaluated by the FDA for safety, quality, or efficacy and distinguishes compounded products from branded GLP-1 drugs.
Compare HumeCare+ program details and terms
Conclusion: Willow vs HumeCare+
In short, choose based on whether you want a structured telehealth program focused on progress tracking and follow-up (Willow) or a bundled, clinician-led protocol that adds glycine, B vitamins, monthly body-composition scans, and a 10%-or-money-back promise (HumeCare+). Pricing evidence shows Willow at 299 starting, while HumeCare+ lists semaglutide from $199/month and tirzepatide protocols from $299/month. Both require clinician approval and note that compounded medications are not FDA-evaluated.
Choose Willow if…
You prioritize a telehealth-first, structured weight management journey with progress tracking tools and scheduled follow-up consultations rather than a medication-only subscription.
Choose HumeCare+ if…
You want a bundled GLP-1 protocol that includes glycine and B vitamins, monthly body-composition scans to track lean mass, and a 10%-or-money-back promise over six months, subject to the program terms.